TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of the Collaborative Life Skills Program
Brief Summary: This study tests the effectiveness of a newly developed integrated school-home behavioral intervention for behaviors related to Attention Deficit Hyperactivity Disorder (ADHD). The intervention is implemented by school-based mental health professionals within school settings.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Stimulant medication therapy, Behavioral: Community-based psychosocial treatment | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Group-based behavior therapy, Drug: Stimulant medication therapy | Intervention Type: BEHAVIORAL; Name: Group-based behavior therapy; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Stimulant medication therapy; Assigned to Arm(s): 1, 2 | Intervention Type: BEHAVIORAL; Name: Community-based psychosocial treatment; Assigned to Arm(s): 1
B: Arm Label: CBT group; Type: EXPERIMENTAL; Interventions: Behavioral: CBT group | Arm Label: Psychopharmacological treatment; Type: ACTIVE_COMPARATOR; Interventions: Drug: Psychopharmacological treatment | Intervention Type: DRUG; Name: Psychopharmacological treatment; Assigned to Arm(s): Psychopharmacological treatment | Intervention Type: BEHAVIORAL; Name: CBT group; Assigned to Arm(s): CBT group
C: Arm Label: Combined therapy; Type: EXPERIMENTAL; Interventions: Drug: atomoxetine, Behavioral: Behavior Modification Therapy | Arm Label: Drug therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: atomoxetine | Intervention Type: DRUG; Name: atomoxetine; Assigned to Arm(s): Combined therapy, Drug therapy | Intervention Type: BEHAVIORAL; Name: Behavior Modification Therapy; Assigned to Arm(s): Combined therapy
D: Arm Label: Business as Usual (BAU); Type: OTHER; Interventions: Other: Business As Usual | Arm Label: Collaborative Life Skills Intervention (CLS); Type: EXPERIMENTAL; Interventions: Behavioral: Collaborative Life Skills Intervention (CLS) | Intervention Type: BEHAVIORAL; Name: Collaborative Life Skills Intervention (CLS); Assigned to Arm(s): Collaborative Life Skills Intervention (CLS) | Intervention Type: OTHER; Name: Business As Usual; Assigned to Arm(s): Business as Usual (BAU)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Oral Morphine Versus Ibuprofen for Post-operative Pain Management in Children: a Randomized Controlled Study
Brief Summary: Children 5-17 years of age who have undergo orthopedic day surgical procedures for definitive management of fractures, tendon release, etc. will be randomized to receive either ibuprofen or oral morphine as needed for pain relief for 48 hours post-operatively at home. Pain will be assessed using the self-report Faces pain scale revised (FPS-R). We hypothesize that oral morphine will result in significantly lower pain scores on the Faces Pain Scale Revised (FPS-R) compared to ibuprofen. It is hoped that the results of this trial will create a new option for post-operative pain management in children.


Options:
A: Arm Label: Patients; Type: N/A; Interventions: N/A
B: Arm Label: Group 1- Received Ibuprofen (N=44); Type: ACTIVE_COMPARATOR; Interventions: Drug: Ibuprofen 600 mg, Drug: Acetaminophen 1000 mg | Arm Label: Group 2- Received Dexamethasone (N=44); Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexamethasone 4 mg, Drug: Acetaminophen 1000 mg | Arm Label: Group 3 - Received Placebo (N=44); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Acetaminophen 1000 mg | Intervention Type: DRUG; Name: Ibuprofen 600 mg; Assigned to Arm(s): Group 1- Received Ibuprofen (N=44) | Intervention Type: DRUG; Name: Dexamethasone 4 mg; Assigned to Arm(s): Group 2- Received Dexamethasone (N=44) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Group 3 - Received Placebo (N=44) | Intervention Type: DRUG; Name: Acetaminophen 1000 mg; Assigned to Arm(s): Group 1- Received Ibuprofen (N=44), Group 2- Received Dexamethasone (N=44), Group 3 - Received Placebo (N=44)
C: Arm Label: ibuprofen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ibuprofen | Arm Label: oral morphine; Type: ACTIVE_COMPARATOR; Interventions: Drug: oral morphine | Intervention Type: DRUG; Name: oral morphine; Assigned to Arm(s): oral morphine | Intervention Type: DRUG; Name: Ibuprofen; Assigned to Arm(s): ibuprofen
D: Arm Label: Morphine; Type: EXPERIMENTAL; Interventions: Drug: Morphine | Arm Label: Ibuprofen; Type: EXPERIMENTAL; Interventions: Drug: Ibuprofen | Intervention Type: DRUG; Name: Morphine; Assigned to Arm(s): Morphine | Intervention Type: DRUG; Name: Ibuprofen; Assigned to Arm(s): Ibuprofen

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Clinical Trial of Selective Laser Trabeculoplasty (SLT) in Open Angle Glaucoma Who Had Been Previously Treated With Complete SLT
Brief Summary: Lasers are important therapy in glaucoma. They are a pivotal point in treatment between medical and surgical care. Over the last 10 years a new laser has emerged as the usual laser treatment: Selective laser trabeculoplasty (SLT). SLT works as well as the older laser used: argon laser trabeculoplasty (ALT). However SLT has many theoretical benefits over ALT including causing less damage to the tissue it affects. One of the potential patient centered benefits of this laser is that it may be repeatable. It is even possible that the old laser ALT may be useable after an SLT treatment. This study aims to uncover whether repeat laser is possible after SLT and if so which laser is more effective (ALT vs SLT). The potential of repeating laser therapies may delay surgical treatment and its complications. Also understanding which laser to use will help eye doctors know how to treat their patients at this point of the disease.


Options:
A: Arm Label: Argon laser trabeculoplasty; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Argon laser trabeculoplasty, Procedure: Selective laser trabeculoplasty | Arm Label: selective laser trabeculoplasty; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Argon laser trabeculoplasty, Procedure: Selective laser trabeculoplasty | Intervention Type: PROCEDURE; Name: Argon laser trabeculoplasty; Assigned to Arm(s): Argon laser trabeculoplasty, selective laser trabeculoplasty | Intervention Type: PROCEDURE; Name: Selective laser trabeculoplasty; Assigned to Arm(s): Argon laser trabeculoplasty, selective laser trabeculoplasty
B: Arm Label: Selective laser trabeculoplasty; Type: EXPERIMENTAL; Interventions: Device: Selective laser trabeculoplasty | Arm Label: Travoprost; Type: ACTIVE_COMPARATOR; Interventions: Drug: Travoprost | Intervention Type: DEVICE; Name: Selective laser trabeculoplasty; Assigned to Arm(s): Selective laser trabeculoplasty | Intervention Type: DRUG; Name: Travoprost; Assigned to Arm(s): Travoprost
C: Intervention Type: DRUG; Name: prednisolone acetate 1%; Assigned to Arm(s): N/A
D: Arm Label: Direct Selective Trabeculoplasty; Type: EXPERIMENTAL; Interventions: Device: Direct Selective Trabeculoplasty | Arm Label: Selective Trabeculoplasty; Type: ACTIVE_COMPARATOR; Interventions: Device: Selective Trabeculoplasty | Intervention Type: DEVICE; Name: Direct Selective Trabeculoplasty; Assigned to Arm(s): Direct Selective Trabeculoplasty | Intervention Type: DEVICE; Name: Selective Trabeculoplasty; Assigned to Arm(s): Selective Trabeculoplasty

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Home Visiting for Low Income, Pregnant Women
Brief Summary: In the Pico-Union/Koreatown community of Los Angeles investigators are designing a preventive health care model that increases the opportunities for families to make healthy choices -- in their homes, schools \& communities. The project's key element is: Lay community health workers (paraprofessionals) - Mentor Mothers (MM) (promotoras) - who make home visits to pregnant mothers \& newly-delivered mothers who have agreed to participate in the research study.

Investigators hope to achieve the following outcomes: 1) lower maternal BMI at 6 months post-birth; 2) longer duration of breastfeeding; 3) less alcohol, smoking, and drug use during pregnancy; and 4) increased and consistent prenatal and postnatal healthcare adherence.

Investigators will implement the study with 6 MMs, who will maintain an average caseload of 16 women each across an 18-month period. Each participant will be visited (or receive the intervention by telephone) twice per month.

Separate Assessment Team members will conduct assessments at: Baseline, within a week of birth of the target child, and 6 months from birth.


Options:
A: Arm Label: implementation strategy; Type: EXPERIMENTAL; Interventions: Other: implementation strategy of Breastfeeding | Arm Label: Conventional intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: implementation strategy of Breastfeeding; Assigned to Arm(s): implementation strategy
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary Advice | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary Advice; Assigned to Arm(s): Intervention
C: Arm Label: In-home Mentor Mother visits; Type: EXPERIMENTAL; Interventions: Behavioral: In-home Mentor Mother visits | Arm Label: Health Information Mailings; Type: EXPERIMENTAL; Interventions: Behavioral: Health Information Mailings | Intervention Type: BEHAVIORAL; Name: In-home Mentor Mother visits; Assigned to Arm(s): In-home Mentor Mother visits | Intervention Type: BEHAVIORAL; Name: Health Information Mailings; Assigned to Arm(s): Health Information Mailings
D: Arm Label: health education; Type: EXPERIMENTAL; Interventions: Other: health education | Arm Label: no health education; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: health education; Assigned to Arm(s): health education

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Continuous Study on Abiding Effect of Acupuncture for Migraine Treatment
Brief Summary: Hypothesis: Acupuncture obtains an abiding effect on migraine prophylaxis Design: A open-label randomized controlled trial. 249 participants will be included. Three arms: acupuncture in acupoint-meridian， non-acupoint-meridian group, and waiting list.


Options:
A: Arm Label: group 1; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: Group 2; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: group 3; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: group 4; Type: SHAM_COMPARATOR; Interventions: Other: acupuncture | Intervention Type: OTHER; Name: acupuncture; Assigned to Arm(s): Group 2, group 1, group 3, group 4
B: Arm Label: acupuncture; Type: EXPERIMENTAL; Interventions: Procedure: acupuncture | Arm Label: topiramate; Type: ACTIVE_COMPARATOR; Interventions: Drug: topiramate | Intervention Type: PROCEDURE; Name: acupuncture; Assigned to Arm(s): acupuncture | Intervention Type: DRUG; Name: topiramate; Assigned to Arm(s): topiramate
C: Intervention Type: DEVICE; Name: Acupuncture; Assigned to Arm(s): N/A
D: Arm Label: acupoint-meridian group; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: sham-acupoint group; Type: OTHER; Interventions: Other: acupuncture | Arm Label: waiting list; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: acupuncture; Assigned to Arm(s): acupoint-meridian group, sham-acupoint group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: Aldosterone receptor blockers reduce cardiac-related morbidity and mortality. Recently, we demonstrated that long-term low-dose spironolactone is clinically safe in many hemodialysis (HD) patients. In the present study, we assess whether low-dose spironolactone treatment reduces the high incidence of cardio- and cerebrovascular (CCV) morbidity and mortality in HD patients. The investigators' hypothesis is that aldosterone receptor blockade by spironolactone reduces the risk of both CCV morbidity and death among HD patients.


Options:
A: Arm Label: spironolactone; Type: EXPERIMENTAL; Interventions: Drug: Spironolactone | Intervention Type: DRUG; Name: Spironolactone; Assigned to Arm(s): spironolactone
B: Arm Label: Losartan; Type: EXPERIMENTAL; Interventions: Drug: Losartan | Arm Label: spirolactone; Type: EXPERIMENTAL; Interventions: Drug: spirolactone | Arm Label: losartan in combination with spirolactone; Type: EXPERIMENTAL; Interventions: Drug: Losartan, Drug: spirolactone | Arm Label: blank control; Type: SHAM_COMPARATOR; Interventions: Other: blank control | Intervention Type: DRUG; Name: Losartan; Assigned to Arm(s): Losartan, losartan in combination with spirolactone | Intervention Type: DRUG; Name: spirolactone; Assigned to Arm(s): losartan in combination with spirolactone, spirolactone | Intervention Type: OTHER; Name: blank control; Assigned to Arm(s): blank control
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: spironolactone | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: spironolactone; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
D: Arm Label: Spironolactone 12.5 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Spironolactone | Arm Label: Spironolactone 25 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Spironolactone | Arm Label: Spironolactone 50 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Spironolactone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Spironolactone | Intervention Type: DRUG; Name: Spironolactone; Assigned to Arm(s): Placebo, Spironolactone 12.5 mg, Spironolactone 25 mg, Spironolactone 50 mg

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Longitudinal Trial About the Effects of Music on Fear of Childbirth and Outcome of Delivery
Brief Summary: The aim of this trial is to find out if active music listening during pregnancy and delivery reliefs fear of childbirth, pain in delivery, need for analgesia during delivery and if there is an effect on delivery complications. Also we try to find out if there is any influence on mother-baby relationship.


Options:
A: Arm Label: Mind in Labor (MIL); Type: EXPERIMENTAL; Interventions: Behavioral: Mind in Labor (MIL): Working with Pain in Childbirth | Arm Label: Treatment As Usual (TAU); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as usual (TAU) | Intervention Type: BEHAVIORAL; Name: Mind in Labor (MIL): Working with Pain in Childbirth; Assigned to Arm(s): Mind in Labor (MIL) | Intervention Type: BEHAVIORAL; Name: Treatment as usual (TAU); Assigned to Arm(s): Treatment As Usual (TAU)
B: Arm Label: Fear of childbirth, music; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Music | Arm Label: Fear of childbirth, control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Nulliparous, music; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Music | Arm Label: Nulliparous, control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Music; Assigned to Arm(s): Fear of childbirth, music, Nulliparous, music
C: Arm Label: Study group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CBT | Arm Label: Control group; Type: SHAM_COMPARATOR; Interventions: Other: Sham | Intervention Type: BEHAVIORAL; Name: CBT; Assigned to Arm(s): Study group | Intervention Type: OTHER; Name: Sham; Assigned to Arm(s): Control group
D: Arm Label: Art therapy group; Type: EXPERIMENTAL; Interventions: Other: Art Therapy and therapeutic conversations | Arm Label: Therapeutic conversation group; Type: ACTIVE_COMPARATOR; Interventions: Other: Therapeutic conversations | Intervention Type: OTHER; Name: Art Therapy and therapeutic conversations; Assigned to Arm(s): Art therapy group | Intervention Type: OTHER; Name: Therapeutic conversations; Assigned to Arm(s): Therapeutic conversation group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Perinatal Nurse Home Visiting Enhanced With mHealth Technology
Brief Summary: This research is being done to test whether mobile technology will reduce possible communication barriers between women and their home visitor; to improve assessing for health problems that could affect their pregnancy; to help in the delivery of information and actions to improve the health of the woman and their child.


Options:
A: Arm Label: Intervention arm; Type: EXPERIMENTAL; Interventions: Behavioral: The SHARE Project | Arm Label: Control arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: The SHARE Project; Assigned to Arm(s): Intervention arm
B: Arm Label: Standard IPV Assessment; Type: EXPERIMENTAL; Interventions: Behavioral: Standard IPV Assessment | Arm Label: Standard DOVE intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Standard IPV Assessment, Behavioral: Standard DOVE Intervention | Intervention Type: BEHAVIORAL; Name: Standard IPV Assessment; Assigned to Arm(s): Standard DOVE intervention, Standard IPV Assessment | Intervention Type: BEHAVIORAL; Name: Standard DOVE Intervention; Assigned to Arm(s): Standard DOVE intervention
C: Intervention Type: BEHAVIORAL; Name: Home Visiting; Assigned to Arm(s): N/A
D: Arm Label: advocacy intervention; Type: EXPERIMENTAL; Interventions: Behavioral: advocacy intervention | Arm Label: Usual community services; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: usual community services | Intervention Type: BEHAVIORAL; Name: advocacy intervention; Assigned to Arm(s): advocacy intervention | Intervention Type: BEHAVIORAL; Name: usual community services; Assigned to Arm(s): Usual community services

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Perinatal Nurse Home Visiting Enhanced With mHealth Technology
Brief Summary: This research is being done to test whether mobile technology will reduce possible communication barriers between women and their home visitor; to improve assessing for health problems that could affect their pregnancy; to help in the delivery of information and actions to improve the health of the woman and their child.


Options:
A: Arm Label: I; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: II; Type: EXPERIMENTAL; Interventions: Other: Home visit by community care coordinators | Intervention Type: OTHER; Name: Home visit by community care coordinators; Assigned to Arm(s): II
B: Arm Label: Health Coach Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Health Coach Intervention | Intervention Type: BEHAVIORAL; Name: Health Coach Intervention; Assigned to Arm(s): Health Coach Intervention
C: Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Study Intervention for Retention (APFU); Type: EXPERIMENTAL; Interventions: Behavioral: Study Intervention for Retention (APFU) | Intervention Type: BEHAVIORAL; Name: Study Intervention for Retention (APFU); Assigned to Arm(s): Study Intervention for Retention (APFU)
D: Arm Label: Standard IPV Assessment; Type: EXPERIMENTAL; Interventions: Behavioral: Standard IPV Assessment | Arm Label: Standard DOVE intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Standard IPV Assessment, Behavioral: Standard DOVE Intervention | Intervention Type: BEHAVIORAL; Name: Standard IPV Assessment; Assigned to Arm(s): Standard DOVE intervention, Standard IPV Assessment | Intervention Type: BEHAVIORAL; Name: Standard DOVE Intervention; Assigned to Arm(s): Standard DOVE intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Perinatal Nurse Home Visiting Enhanced With mHealth Technology
Brief Summary: This research is being done to test whether mobile technology will reduce possible communication barriers between women and their home visitor; to improve assessing for health problems that could affect their pregnancy; to help in the delivery of information and actions to improve the health of the woman and their child.


Options:
A: Arm Label: Clinic group 1; Type: EXPERIMENTAL; Interventions: Behavioral: mHealth messaging | Arm Label: Clinic group 2; Type: EXPERIMENTAL; Interventions: Behavioral: Transport Payments | Arm Label: Clinic group 3; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: mHealth messaging; Assigned to Arm(s): Clinic group 1 | Intervention Type: BEHAVIORAL; Name: Transport Payments; Assigned to Arm(s): Clinic group 2
B: Arm Label: Standard IPV Assessment; Type: EXPERIMENTAL; Interventions: Behavioral: Standard IPV Assessment | Arm Label: Standard DOVE intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Standard IPV Assessment, Behavioral: Standard DOVE Intervention | Intervention Type: BEHAVIORAL; Name: Standard IPV Assessment; Assigned to Arm(s): Standard DOVE intervention, Standard IPV Assessment | Intervention Type: BEHAVIORAL; Name: Standard DOVE Intervention; Assigned to Arm(s): Standard DOVE intervention
C: Arm Label: Philani Intervention Model+MOVIE (PIM+M); Type: EXPERIMENTAL; Interventions: Behavioral: Philani Intervention Model+MOVIE (PIM+M) | Arm Label: Philani Intervention Model (PIM); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Philani Intervention Model (PIM) | Intervention Type: BEHAVIORAL; Name: Philani Intervention Model+MOVIE (PIM+M); Assigned to Arm(s): Philani Intervention Model+MOVIE (PIM+M) | Intervention Type: BEHAVIORAL; Name: Philani Intervention Model (PIM); Assigned to Arm(s): Philani Intervention Model (PIM)
D: Arm Label: Cell-phone assisted; Type: EXPERIMENTAL; Interventions: Device: Cell-phone | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Cell-phone; Assigned to Arm(s): Cell-phone assisted

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Copenhagen Rehabilitation Trial Part 2: Telemedicine as a Means to Achieve Good Diabetes Control Among Patients With Type 2 Diabetes
Brief Summary: The aim of the study is to investigate the effect of telemedicine among the group of type-2-diabetics who, despite rehabilitation, remain poorly regulated. To describe the patients with regards to vulnerability and social resources and to determine wich groups benefit the most from telemedicine.


Options:
A: Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as usual | Arm Label: A; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse-led case management | Intervention Type: BEHAVIORAL; Name: Nurse-led case management; Assigned to Arm(s): A | Intervention Type: BEHAVIORAL; Name: Treatment as usual; Assigned to Arm(s): B
B: Arm Label: Internet Intervention; Type: EXPERIMENTAL; Interventions: Other: Internet Intervention | Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Internet Intervention; Assigned to Arm(s): Internet Intervention
C: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention Group, treatment algorithms; Type: EXPERIMENTAL; Interventions: Other: Treatment Algorithms | Intervention Type: OTHER; Name: Treatment Algorithms; Assigned to Arm(s): Intervention Group, treatment algorithms
D: Arm Label: Telemedicine; Type: EXPERIMENTAL; Interventions: Behavioral: Telemedicine | Arm Label: Standard treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Telemedicine; Assigned to Arm(s): Telemedicine

Answer: D